Cargando…

Use of glucocorticoids in the management of immunotherapy‐related adverse effects

Immune checkpoint inhibitors (ICIs) activate host antitumor immunity to kill tumor cells. However, ICI therapy may be accompanied by a series of immunotherapy‐related adverse effects (irAEs) caused by activated autoreactive T cells. Glucocorticoids are the mainstream therapy for irAEs. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hanping, Zhou, Jiaxin, Guo, Xiaoxiao, Li, Yue, Duan, Lian, SI, Xiaoyan, Zhang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2020
Materias:	Clinical Guideline
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529549/ https://www.ncbi.nlm.nih.gov/pubmed/32893490 http://dx.doi.org/10.1111/1759-7714.13589

Ejemplares similares

Management of immune checkpoint inhibitor‐related dermatologic adverse events
por: Si, Xiaoyan, et al.
Publicado: (2019)

Management of immune checkpoint inhibitor‐related rheumatic adverse events
por: Zhou, Jiaxin, et al.
Publicado: (2019)

Recommendation for the diagnosis and management of immune checkpoint inhibitor related infections
por: Lu, Minya, et al.
Publicado: (2020)

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events
por: Zhuang, Junling, et al.
Publicado: (2020)

Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity
por: Guo, Xiaoxiao, et al.
Publicado: (2019)

Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction
por: Duan, Lian, et al.
Publicado: (2020)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis
por: Wang, Hanping, et al.
Publicado: (2019)

Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy
por: Liu, Xiaowei, et al.
Publicado: (2020)

Clinical recommendations on diagnosis and treatment of immune checkpoint inhibitor‐induced renal immune‐related adverse events
por: Zheng, Ke, et al.
Publicado: (2020)

Clinical recommendations for perioperative immunotherapy‐induced adverse events in patients with non‐small cell lung cancer
por: Ni, Jun, et al.
Publicado: (2021)

Management of immune checkpoint inhibitor‐related adverse events: A review of case reports
por: Si, Xiaoyan, et al.
Publicado: (2020)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated adverse events in the digestive system
por: Li, Yue, et al.
Publicado: (2020)

Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID‐19 epidemic
por: Zhao, Zhe, et al.
Publicado: (2020)

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related adverse reactions in the nervous system
por: Shi, Jiayu, et al.
Publicado: (2019)

Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events
por: Song, Peng, et al.
Publicado: (2020)

Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer
por: Huang, Dingzhi, et al.
Publicado: (2023)

Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis
por: Park, So Young, et al.
Publicado: (2018)

Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases
por: Liu, Liping, et al.
Publicado: (2020)

Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
por: Wang, Wenxian, et al.
Publicado: (2022)

Chinese guidelines on the management of liver cirrhosis (abbreviated version)
por: Xu, Xiao-Yuan, et al.
Publicado: (2020)

Chinese guidelines on management of hepatic encephalopathy in cirrhosis
por: Xu, Xiao-Yuan, et al.
Publicado: (2019)

Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)
por: You, Hong, et al.
Publicado: (2023)

Chinese expert consensus on the management of aneurysmal subarachnoid hemorrhage-related hydrocephalus
por: Pu, Jun, et al.
Publicado: (2023)

Chinese expert consensus on the treatment of MMD
por: Bao, Xiang-Yang, et al.
Publicado: (2023)

Chinese expert consensus on diagnosis and management of acquired respiratory‐digestive tract fistulas
por: Wang, Hongwu, et al.
Publicado: (2018)

Guidelines on the diagnosis and the current management of headache and related disorders
por: Ravishankar, K., et al.
Publicado: (2011)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
por: Maus, Marcela V, et al.
Publicado: (2020)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
por: Brahmer, Julie R, et al.
Publicado: (2021)

Strategies for improving the management of immune-related adverse events
por: Naing, Aung, et al.
Publicado: (2020)

Rapid advice guidelines for management of children with COVID-19
por: Liu, Enmei, et al.
Publicado: (2020)

Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of the management of high-risk population
por: Wang, Yilong, et al.
Publicado: (2020)

Strategies for the use of Ginkgo biloba extract, EGb 761(®), in the treatment and management of mild cognitive impairment in Asia: Expert consensus
por: Kandiah, Nagaendran, et al.
Publicado: (2020)

Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of spontaneous subarachnoid haemorrhage
por: Dong, Yi, et al.
Publicado: (2019)

Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition)
por: Ding, Song-Ze, et al.
Publicado: (2022)

Chinese multidisciplinary expert consensus: Guidelines on percutaneous transthoracic needle biopsy
por: Guo, Zhi, et al.
Publicado: (2018)

Messages for patients and relatives from the 2021 update of the guideline on acute therapy and management of anaphylaxis
por: Ring, Johannes, et al.
Publicado: (2021)

2019 Chinese guideline for the management of hypertension in the elderly
por: Hua, Qi, et al.
Publicado: (2019)

Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis
por: Fan, Yuhua, et al.
Publicado: (2020)

Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications
por: Abu-Alfa, Ali K., et al.
Publicado: (2022)

Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists
por: Jin, Huijuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fogf3hk5u61egtbdm55eu2ca8g